Details for New Drug Application (NDA): 210976
✉ Email this page to a colleague
The generic ingredient in PENICILLAMINE is penicillamine. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the penicillamine profile page.
Summary for 210976
Tradename: | PENICILLAMINE |
Applicant: | Watson Labs Inc |
Ingredient: | penicillamine |
Patents: | 0 |
Suppliers and Packaging for NDA: 210976
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PENICILLAMINE | penicillamine | CAPSULE;ORAL | 210976 | ANDA | Actavis Pharma, Inc. | 0591-4171 | 0591-4171-01 | 100 CAPSULE in 1 BOTTLE (0591-4171-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
Approval Date: | Jun 24, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription